Physician profile
Larry Rosenberg
NPI 1598710212
$640.52
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $309 · 2020: $206 · 2022: $125.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2022 | |
| Tactile Systems Technology INC | $112.36 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $108.53 | 2019 | |
| Genzyme Corporation | $48.35 | 2019 | |
| Sanofi-Aventis U.S. LLC | $40.78 | 2019 | |
| Amgen INC. | $34.07 | 2019-2020 | |
| Daiichi Sankyo INC. | $33.52 | 2019-2020 | |
| Celgene Corporation | $18.36 | 2020 | |
| Taiho Oncology, INC. | $17.64 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $17.02 | 2019 | |
| Merck Sharp & Dohme LLC | $15.83 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.47 | 2019 | |
| Janssen Biotech, INC. | $14.80 | 2020 | |
| Pfizer INC. | $13.34 | 2020 | |
| Rigel Pharmaceuticals, INC. | $13.02 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $12.43 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.